Forbion Growth Management B.V. bought $5.0M of enGene (ENGN)

Executed Oct 30 2024, disclosed Nov 1 2024, 2 days later.

Value, as filed

$5.0M

561,797 sh × $8.90

Executed

Oct 30 2024

the trade date, as filed

Disclosed

Nov 1 2024

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

-2.1%

-4.1% from execution

Over the 21 trading sessions from the disclosed entry session (Nov 1 2024), the stock returned -2.1% (delay-adjusted); from the execution session (Oct 30 2024), -4.1%. Derived: entry at the session's open, exit at the close 20 sessions later.

The filer

FV Forbion Growth Management B.V. 10% owner profile →

Forbion Growth Management B.V. (10% owner) filed 1 Form 4 report as a reporting entity in the past 24 months (0 purchases, 1 sale), most often in NewAmsterdam Pharma Company N.V. (NAMS). The largest single filing was $11.7M of NAMS (462,288 sh across 5 lots, as filed), executed Dec 10 2024.

The name

ENGN ENGN ENGN ticker → Insider filings, newest first→ View the original filing at www.sec.gov→